Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Regulation of cyclin D1 expression by autocrine IGF-I in human BON neuroendocrine tumour cells

Abstract

Constitutive expression of cyclin D1 is a frequent abnormality in human cancer and sustains the transformed phenotype. We have previously demonstrated that cyclin D1 is constitutively expressed in human BON neuroendocrine tumour cells due to an autocrine insulin-like growth factor-I (IGF-I) loop. Here we examine the regulation of cyclin D1 expression by endogenously released IGF-I in BON cells. Cyclin D1 expression in these cells was found to be dependent on phosphatidylinositol 3-kinase (PI3-K), but independent of the extracellular signal-regulated kinase cascade. Ras- and Rac-GTPases were found to be upstream activators of cyclin D1 expression, whereas protein kinase B/AKT and nuclear factor kappa B (NFκB) could be established as downstream mediators of cyclin D1 transcription in response to endogenously released IGF-I in these cells. In addition, the Ras/PI3-K/AKT/Rac/NFκB/cyclin D1 signaling cascade triggered by endogenously released IGF-I is sufficient to sustain Rb phosphorylation and cdk4 kinase activity in BON cells. In conclusion, our data provide the first comprehensive map of the signaling events elicited by endogenously released IGF-I leading to constitutive cyclin D1 expression in human neuroendocrine tumour cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

AKT:

protein kinase B

Cdk:

cyclin-dependent kinase

DNM:

Dulbeccos-F12 nut mix

ECL:

enhanced chemoluminescence

EMSA:

electrophoretic mobility shift assay

ERK:

extracellular signal-regulated kinase

FBS:

foetal bovine serum

IGF-I:

insulin-like growth factor-I

IGF-IN-Ab:

IGF-I immunoneutralizing antibody

IGF-IR:

insulin-like growth factor-I receptor

MEK:

mitogen-activated protein kinase kinase

NFκB:

nuclear factor kappa B

PI3-K:

phosphatidylinositol 3-kinase

Rb:

retinoblastoma protein

References

  • Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG . (1995). J. Biol. Chem., 270, 23589–23597.

  • Arber N, Doki Y, Han EK-H, Sgambato A, Zhou P, Kim N, Delohery T, Klein MG, Holt PR and Weinstein IB . (1997). Cancer Res., 57, 1569–1574.

  • Cheng HL, Steinway ML, Russell JW and Feldman EL . (2000). J. Biol. Chem., 275, 27197–27204.

  • Coolican SA, Samuel DS, Ewton DZ, McWade FJ and Florini JR . (1997). J. Biol. Chem., 272, 6653–6662.

  • Downward J . (1997). Adv. Second Messenger Phosphoprotein Res., 31, 1–10.

  • Evers BM, Ishizuka J, Townsend Jr CM and Thompson J . (1994). Ann. NY Acad. Sci., 733, 393–406.

  • Gille H and Downward J . (1999). J. Biol. Chem., 274, 22033–22040.

  • Guillemot L, Levy A, Zhao ZJ, Bereziat G and Rothhut B . (2000). J. Biol. Chem., 275, 26349–26358.

  • Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B and Pestell RG . (2001). Cytokine Growth Factor Rev., 12, 73–90.

  • Kuemmerle JF, Zhou H and Bowers JG . (2004). Am. J. Physiol. Gastrointest. Liver Physiol., 286, G412–G419.

  • Lavoie JN, ĹAllemain G, Brunet A, Müller R and Poussegur J . (1996). J. Biol. Chem., 271, 20608–20616.

  • Lin YZ, Yao SY, Veach RA, Torgerson TR and Hawiger J . (1995). J. Biol. Chem., 270, 14255–14258.

  • Oberg K . (2002). Curr. Opin. Oncol., 14, 38–45.

  • Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR and Hershenson MB . (1999). J. Biol. Chem., 274, 22065–22071.

  • Roovers K, Davey G, Zhu X, Bottazzi ME and Assoian RK . (1999). Mol. Biol. Cell, 10, 3197–3204.

  • Sherr CJ . (1996). Science, 274, 1672–1677.

  • von Wichert G, Jehle PM, Hoeflich A, Koschnik S, Dralle H, Wolf E, Wiedenmann B, Boehm BO, Adler G and Seufferlein T . (2000). Cancer Res., 60, 4573–4581.

  • Weinstein IB . (2000). Carcinogenesis, 21, 857–864.

  • Zahir N, Lakins JN, Russell A, Ming W, Chatterjee C, Rozenberg GI, Marinkovich MP and Weaver VM . (2003). J. Cell Biol., 163, 1397–1407.

  • Zhou P, Jiang W, Zhang Y-J, Kahn SM, Schieren I, Santella RM and Weinstein IB . (1995). Oncogene, 11, 571–580.

Download references

Acknowledgements

We thank P Angel (DKFZ Heidelberg/Germany) for the ΔFos plasmid, J Downward (ICRF in London/UK), for the Ras-, Rac- and dnMEK plasmids and RM Schmid (Medical University of Ulm/Germany) for the AP-1- and cyclin D1 reporter plasmids.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Seufferlein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

von Wichert, G., Haeussler, U., Greten, F. et al. Regulation of cyclin D1 expression by autocrine IGF-I in human BON neuroendocrine tumour cells. Oncogene 24, 1284–1289 (2005). https://doi.org/10.1038/sj.onc.1208264

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208264

Keywords

Search

Quick links